Table 2.
Relationship of MAPKAPK2 protein levels with the clinicopathological characteristics of 93 glioma patients detected by IHC.
| Variable | Number (n) |
MAPKAPK2 staining | |||
|---|---|---|---|---|---|
| Low (%) | High (%) | Χ 2 | p | ||
| Gender | 0.824 | 0.364 | |||
| Male | 56 | 37 (66.1) | 19 (33.9) | ||
| Female | 37 | 21 (56.8) | 16 (43.2) | ||
| Age | 0.001 | 0.981 | |||
| <50 years | 40 | 25 (62.5) | 15 (37.5) | ||
| ≥50 years | 53 | 33 (62.3) | 20 (37.7) | ||
| Tumor size | 2.421 | 0.120 | |||
| <5 cm | 30 | 21 (70.0) | 9 (30.0) | ||
| ≥5 cm | 28 | 14 (50.0) | 14 (50.0) | ||
| WHO grade | 15.437 | 0.000 | |||
| Low (I–II) | 24 | 23 (95.8) | 1 (4.2) | ||
| High (III–IV) | 69 | 35 (50.7) | 34 (49.3) | ||
WHO, World Health Organization.